Company Overview - 圣桐特医 is a leading provider of specialized medical foods in China, focusing on the development, production, and sales of these products [1][2] - The company submitted its listing application to the Hong Kong Stock Exchange on December 5, 2023, with 中信证券 as the sole sponsor [1] - 圣桐特医 holds the top position among domestic specialized medical food brands in China, with a market share of 6.3% in the overall specialized medical food market and 9.5% in the infant specialized medical food market [1][2] Financial Performance - The company recorded revenues of 491 million RMB, 654 million RMB, 834 million RMB, and 397 million RMB for the fiscal years 2022, 2023, 2024, and the first half of 2025, respectively [3] - The annual/profit and total comprehensive income for the same periods were 83.9 million RMB, 170 million RMB, 94.1 million RMB, and 88.5 million RMB [4] - The gross profit margins for the fiscal years 2022, 2023, 2024, and the first nine months of 2025 were 71.8%, 71.0%, 71.0%, and 69.8%, respectively [5] Industry Overview - The specialized medical food market in China is experiencing rapid growth, with the market size projected to increase from 7.3 billion RMB in 2019 to 23.2 billion RMB in 2024, reflecting a compound annual growth rate (CAGR) of 26.1% [6] - The infant specialized medical food market is expected to grow from 4.5 billion RMB in 2019 to 13.5 billion RMB in 2024, with a CAGR of 24.7% [7] - The non-infant specialized medical food market is also expanding, with a projected growth from 2.8 billion RMB in 2019 to 9.7 billion RMB in 2024, achieving a CAGR of 28.3% [7]
新股消息 圣桐特医二次递表港交所 稳居本土特医食品品牌榜首
Jin Rong Jie·2025-12-07 04:54